Ovid Therapeutics Inc. buy Lokrim
Start price
29.09.25
/
20%
€1.17
Target price
29.09.26
-
Performance (%)
22.22%
End price
10.10.25
€1.43
Summary
This prediction ended on 10.10.25 with a price of €1.43. The prediction had a final performance of 22.22%. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ovid Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to Lokrim what are the pros and cons of Ovid Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Lokrim for this prediction
In the thread Ovid Therapeutics Inc. diskutieren
Buy Ovid Therapeutics Inc.